[1] G. A. Peyman, J. T. Paque and H. I. Meisels, “Postoperative Endophthalmitis: A Comparison of Methods for Treatment and Prophylaxis with Gentamicin,” Ophthalmic Surgery, Vol. 6, No. 1, 1975, pp. 45-55.
[2] A. Pathengay, M. Khera, T. Das, S. Sharma, D. Miller and H. W. Flynn Jr., “Acute Postoperative Endophthalmitis Following Cataract Surgery: A Review,” Asia-Pacific Journal of Ophthalmology, Vol. 1, No. 1, 2012, pp. 35-42. http://dx.doi.org/10.1097/APO.0b013e31823e574b
[3] C. B. Walker and C. M. Claoue, “Incidence of Conjunctival Colonisation by Bacteria Capable of Causing Post-Operative Endophthalmitis,” Journal of the Royal Society of Medicine, Vol. 79, No. 9, 1986, pp. 520-521.
[4] M. G. Speaker, F. A. Milch, M. K. Shah, W. Eisner and B. N. Kreiswirth, “Role of External Bacterial Flora in the Pathogenesis of Acute Postoperative Endophthalmitis,” Ophthalmology, Vol. 98, No. 5, 1991, pp. 639-649.
http://dx.doi.org/10.1016/S0161-6420(91)32239-5
[5] G. W. Denton, “Chlorhexidine,” In: S. S. Block, Ed., Disinfection, Sterilization, and Preservation, 5th Edition. Lippincot Williams & Wilkins, Philadelphia, 2001, pp. 321-336.
[6] N. M. Sergienko, Y. N. Kondratenko, N. V. Chumak and A. Daneshmand, “Results of Prophylaxis of Bacterial Endophthalmitis in Cataract Surgery,” Proceedings of The Joint Congress of SOE/AAO, Geneva, June 2011, p. 51.
[7] K. Green, V. Livingston, K. Browman and D. S. Hull, “Chlorhexidine Effects on Corneal Epithelium and Endothelium,” Archives of Ophthalmology, Vol. 98, No. 7, 1980, pp. 1273-1278.
http://dx.doi.org/10.1001/archopht.1980.01020040125020
[8] N. L. Burstein, “Preservative Cytotoxic Threshold for Benzalkonium Chloride and Chlorhexidine Digluconate in Cat and Rabit Corneas,” Journal Investigative Ophthalmology & Visual Science, Vol. 19, No. 3, 1980, pp. 308-313.
[9] A. W. Bauer, W. M. Kirby, J. C. Sherris and M. Turck, “Antibiotic Susceptibility Testing by Standardized Single Disc Method,” American Journal of Clinical Pathology, Vol. 45, No. 4, 1966, pp. 493-496.
[10] L. D. Perry and C. Skaggs, “Preoperative Topical Antibiotics and Lash Trimming in Cataract Surgery,” Ophthalmic Surgery, Vol. 8, No. 5, 1977, pp. 44-48.
[11] S. J. Isenberg, L. Apt, R. Yoshimori, C. Pham and N. K. Lam, “Efficacy of Topical Povidone-Iodine during the First Week after Ophthalmic Surgery,” American Journal of Ophhalmology, Vol. 124, No. 1, 1997, pp. 31-35.
[12] T. J. Liesegang, “Use of Antimicrobials to Prevent Postoperative Infection in Patients with Cataracts,” Current Opinion in Ophthalmology, Vol. 12, No. 1, 2001, pp. 68-74.
http://dx.doi.org/10.1097/00055735-200102000-00012
[13] T. A. Ciulla, M. B. Starr and S. Masket, “Bacterial Endophthalmitis Prophylaxis for Cataract Surgery: An Evidence-Based Update,” Ophthalmology, Vol. 109, No. 1, 2002, pp. 13-24.
http://dx.doi.org/10.1016/S0161-6420(01)00899-5
[14] A. Safar and M. C. Dellimore, “The Effect of Povidone Iodine Flush versus Drops on Conjunctival Colonization before Intravitreal Injections,” International Ophthalmology, Vol. 27, No. 5, 2007, pp. 307-312.
http://dx.doi.org/10.1007/s10792-007-9073-6
[15] D. S. Hughes and R. J. Hill, “Infectious Endophthalmitis after Cataract Surgery,” British Journal of Ophthalmology, Vol. 78, No. 3, 1994, pp. 227-232.
http://dx.doi.org/10.1136/bjo.78.3.227
[16] M. N. Shi, H. J. Guan, Y. J. Ye, M. S. Chen and C. T. Yu, “Comparative Study of Gentamycin and Povidone-Iodine on Eliminating the Conjunctival Bacteria,” Chinese Journal of Ophthalmology, Vol. 44, No. 12, 2008, pp. 1098-1102.
[17] J. Feys, A. Salvanet-Bouccata, J. P. Emond and A. Dublanchet, “Vancomycin Prophylaxis and Intraocular Contamination during Cataract Surgery,” Journal of Cataract Refractive Surgery, Vol. 23, No. 6, 1997, pp. 894-897.
http://dx.doi.org/10.1016/S0886-3350(97)80250-7
[18] J. C. Lloyd and R. Braga-Mele, “Incidence of Postoperative Endophthalmitis in a High-Volume Cataract Surgicentre in Canada,” Canadian Journal Ophthalmology, Vol. 44, No. 3, 2009, pp. 288-292.
http://dx.doi.org/10.3129/i09-052
[19] G. A. Peyman, P. L. Lee and D. V. Seal, “Endophthalmitis,” Martin Dunitz, London, 2004.
[20] M. B. Hamill, M. S. Osato and K. R. Wilhelmus, “Experimental Evaluation of Chlorhexidine Gluconate for Ocular Antisepsis,” Antimicrobial Agents and Chemotherapy, Vol. 26, No. 6, 1984, pp. 793-796.
http://dx.doi.org/10.1128/AAC.26.6.793
[21] M. T. Suller and A. D. Russell, “Antibiotic and Biocide Resistance in Methicillin-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococcus,” Journal of Hospital Infection, Vol. 43, No. 4, 1999, pp. 281-291.
http://dx.doi.org/10.1016/S0195-6701(99)90424-3
[22] E. Dabrowska, M. Letko, W. Roszkowska-Jakimiec, R. Letko and J. Sadowski, “Effect of Chlorhexidine Mouthrinse on Cathepsin C Activity in Human Saliva,” Advances in Medical Sciences, Vol. 51, No. 1, 2006, pp. 96-99.
[23] T. Gershanik, S. Benzeno and S. Benita, “Interaction of a Self-Emulsifying Lipid Drug Delivery System with the Everted Rat Intestinal Mucosa as a Function of Droplet Size and Surface Charge,” Pharmaceutical Research, Vol. 15, No. 6, 1998, pp. 863-869.
http://dx.doi.org/10.1023/A:1011968313933
[24] S. Tamilvanan, “Oil-in-Water Lipid Emulsions: Implications for Parenteral and Ocular Delivering Systems,” Progress in Lipid Research, Vol. 43, No. 6, 2004, pp. 489-533. http://dx.doi.org/10.1016/j.plipres.2004.09.001
[25] Y. Rojanasakul and J. R. Robinson, “Transport Mechanisms of the Cornea: Characterization of Barrier Permselectivity,” International Journal of Pharmaceutics, Vol. 55, No. 2-3, 1989, pp. 237-246.
http://dx.doi.org/10.1016/0378-5173(89)90047-1
[26] J. Liaw, Y. Rojanasakul and J. R. Robinson, “The Effect of Drug Charge Type and Charge Density on Corneal Transport,” International Journal of Pharmaceutics, Vol. 88, No. 1-3, 1992, pp. 111-124.
http://dx.doi.org/10.1016/0378-5173(92)90308-O